Literature DB >> 7252153

Increased Fc receptor activity in monocytes from patients with rheumatoid arthritis: a study of monocyte binding and catabolism of soluble aggregates of IgG in vitro.

S Katayama, D Chia, H Nasu, D W Knutson.   

Abstract

We studied the binding and catabolic function of adherent monocytes from patients with rheumatoid arthritis (RA) and normal subjects using stable, heat aggregates of IgG125I (A-IgG) as a model for soluble immune complexes. Scatchard plots of 4 degrees C binding data showed that RA monocytes had increased binding avidity and higher maximal binding capacity for A-IgG compared with monocytes from normal subjects. These data suggest that RA monocytes have increased numbers of Fc receptors for IgG, although a concomitant increase in the avidity of individual Fc receptors could not be excluded. At 37 degrees C, RA monocytes; kinetic analysis suggested that increases in catabolized A-IgG were due to increased binding of A-IgG with no change in the fractional rates of catabolism. Latex titers of RA patients correlated with the number of Fc receptors detected on RA monocytes. Mononuclear phagocytes from RA patients are often exposed to endogenous immune complexes that may be present in the blood of such patients; immune complexes may stimulate monocytes and possibly other mononuclear phagocytes to increase their capacity to bind and catabolize soluble immune complexes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7252153

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Dimers and multimers of monoclonal IgG1 exhibit higher in vitro binding affinities to Fcgamma receptors.

Authors:  Yin Luo; Zhaojiang Lu; Stephen W Raso; Clifford Entrican; Bruce Tangarone
Journal:  MAbs       Date:  2009-09-24       Impact factor: 5.857

2.  Defective hepatic handling of IgA immune aggregates by mice with experimental IgA nephropathy.

Authors:  E González; J González-Cabrero; J Egido
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

3.  Blood clearance and tissue localization of soluble aggregates of IgG in NZB/W and NZB mice.

Authors:  D W Knutson; D Chia; E V Barnett; L Levy
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

4.  Effect of gold salt treatment on the receptor binding activity of monocytes and macrophages isolated from rats with adjuvant arthritis.

Authors:  D R Haynes; I R Garrett; B Vernon-Roberts
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

Review 5.  Fc receptor--more answers, more questions.

Authors:  L Fornůsek; V Vĕtvicka
Journal:  Folia Microbiol (Praha)       Date:  1984       Impact factor: 2.099

6.  Spontaneous release of angiotensin converting enzyme and interleukin 1 beta from peripheral blood monocytes from patients with rheumatoid arthritis under a serum free condition.

Authors:  M Goto; M Fujisawa; A Yamada; T Okabe; F Takaku; M Sasano; K Nishioka
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

7.  Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta.

Authors:  J B Allen; H L Wong; P M Guyre; G L Simon; S M Wahl
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

8.  Mononuclear phagocytes in rheumatoid arthritis: Fc-receptor expression by peripheral blood monocytes.

Authors:  S D Carter; J T Bourne; C J Elson; C W Hutton; R Czudek; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

9.  Human monocyte binding of homologous monomer and complexed IgG.

Authors:  S D Carter; R G Leslie; W G Reeves
Journal:  Immunology       Date:  1982-08       Impact factor: 7.397

10.  Constitutive production of angiotensin converting enzyme from rheumatoid nodule cells under serum free conditions.

Authors:  M Goto; M Sasano; M Fuzisawa; T Okabe; K Nishizawa
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.